IL22 and psoriasis: Then, we verified the results in psoriatic lesions and a psoriasis model in vitro by stimulating keratinocytes with IL-17A, IL-22, IL-1α, oncostatin M, and TNF-α (M5) (Rabeony et al., 2014; Li et al., 2019).